Content
[Immuno-Oncology Newsletter - Edition 8] Next-Gen Oncology: From Targeted Therapies to Translational Tools
This exclusive monthly publication #7 brings you cutting-edge advancements and premium solutions from top suppliers in the field. Carefully curated to keep you at the
Rethinking Apoptosis Detection: Streamlined Accuracy with Dojindo
Discover how Dojindo’s Apoptosis (Annexin V) Plate Assay Kit simplifies early apoptosis detection—without the need for flow cytometry.
This user-friendly, plate-based assay enables
[Tebubio Newsletter - Edition 2] Everything You Need, in One Place
Stay ahead in your research with your monthly Tebubio newsletter—your go-to source for innovative reagents, expert services, and insightful articles. Curated to bring you the most relevant products, services
Tebubio at the next ELRIG - Therapeutic Oligonucleotides 2025 congress
We are pleased to announce that Tebubio will attend the next Therapeutic Oligonucleotides 2025 congress organised by ELRIG, on May 14–15, 2025, at AstraZeneca’s R&D site in Gothenburg, Sweden.
Development and Imaging Validation of Fluorescent Lipid Nanoparticles for RNA Delivery Applicable to Personalized In Vitro Oncology Models
Discover how Tebubio's innovative LNP platform enables real-time tracking of RNA delivery in oncology models. Explore our latest findings and applications for personalized medicine.
Important Notice: Delivery Suspension in Spain and Portugal
Important Notice: Delivery Suspension in Spain and Portugal
In light of the challenging circumstances caused by the widespread power outage, we at Tebubio wish to express our deepest
[Immuno-Oncology Newsletter - Edition 7] From RNA to TME: Tools & Insights to Accelerate Immuno-Oncology Research
This exclusive monthly publication #7 brings you cutting-edge advancements and premium solutions from top suppliers in the field. Carefully curated to keep you at the
Alzheimer’s Amyloid-β Accelerates Cell Senescence and Suppresses SIRT1 in Human Neural Stem Cells
In this blog, discover three assay kits developed by our partner Dojindo to accurately quantify and detect SA-β-Gal activity, and to explore a broad range of cellular processes linked to senescence.
Powering Immuno-Oncology Research: Tebubio’s Selected iXCells Biotechnologies Immune Cell Range
Boost the reliability of your Immuno-Oncology research with Tebubio’s expert selection of iXCells immune cells.
From fresh PBMCs to CD4+, CD8+, NK cells and beyond—this resource highlights the
Gamma Delta T Cells : A promising Avenue for Novel Cancer Immunotherapies
In this blog, we delve into the potential of Gamma Delta (γδ) T cells in the development of new cancer treatment, and how thanks to the tools developed by our partner BPS Bioscience we can support you
Bispecific Antibodies: A Revolution in Cancer Treatment
In this blog, we will delve into how BITE antibodies, are transforming cancer treatment strategies, with a special focus on the tools developed by our partner, BPS Biosciences, to help you develop and